SOLV · 10-Q · 2026Q2 · Full report
Market Demand Trends
Solventum Corp · 2026-08-05 · Importance 58 · Surprise 42 · In source text
Second-quarter 2026 sales benefited from approximately $125 million of advanced customer orders placed ahead of Solventum’s July 2026 U.S. ERP deployment. Management expects third-quarter sales to be negatively affected as customers reduce inventory to normal levels. MedSurg sales increased 12.7%, with approximately $85 million of growth attributable to advanced ordering, while Dental Solutions sales increased 17.0%, including approximately $35 million from advanced ordering. Underlying demand was supported by volume in I.V. site management and negative pressure wound therapy, as well as restorative, prevention, and orthodontic dental solutions.
Key facts
- Approximately $85 million (7.0%) of MedSurg's organic growth in the quarter was due to advanced order timing ahead of the Company's U.S. ERP deployment. source
- During the second quarter 2026, sales growth for the three months ended June 30, 2026 benefited by approximately $125 million due to advanced customer ordering related to the Company's July 2026 U.S. ERP deployment. source
- The Company anticipates that sales in the third quarter of 2026 will be negatively impacted as customers reduce inventory to normal levels following the advanced ordering. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | +5.7% | During the second quarter 2026, sales growth for the three months ended June 30, 2026 benefited by approximately $125 million due to… |
| revenue | positive | realized | +3.9% | Approximately $85 million (7.0%) of MedSurg's organic growth in the quarter was due to advanced order timing ahead of the Company's U.S.… |
| revenue | negative | probable | — | The Company anticipates that sales in the third quarter of 2026 will be negatively impacted as customers reduce inventory to normal levels… |